Literature DB >> 27016031

Genome Editing of Structural Variations: Modeling and Gene Correction.

Chul-Yong Park1, Jin Jea Sung1, Dong-Wook Kim2.   

Abstract

The analysis of chromosomal structural variations (SVs), such as inversions and translocations, was made possible by the completion of the human genome project and the development of genome-wide sequencing technologies. SVs contribute to genetic diversity and evolution, although some SVs can cause diseases such as hemophilia A in humans. Genome engineering technology using programmable nucleases (e.g., ZFNs, TALENs, and CRISPR/Cas9) has been rapidly developed, enabling precise and efficient genome editing for SV research. Here, we review advances in modeling and gene correction of SVs, focusing on inversion, translocation, and nucleotide repeat expansion.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  engineered nucleases; gene correction; genome editing; inversion; short nucleotide repeat; translocation

Mesh:

Year:  2016        PMID: 27016031     DOI: 10.1016/j.tibtech.2016.02.011

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  8 in total

Review 1.  CRISPR-Cas-mediated chromosome engineering for crop improvement and synthetic biology.

Authors:  Michelle Rönspies; Annika Dorn; Patrick Schindele; Holger Puchta
Journal:  Nat Plants       Date:  2021-05-06       Impact factor: 15.793

Review 2.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

3.  Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9.

Authors:  Chul-Yong Park; Jin Jea Sung; Sang-Hwi Choi; Dongjin R Lee; In-Hyun Park; Dong-Wook Kim
Journal:  Nat Protoc       Date:  2016-10-06       Impact factor: 13.491

Review 4.  CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling.

Authors:  Jiaqi Liu; Yangzhong Zhou; Xiaolong Qi; Jia Chen; Weisheng Chen; Guixing Qiu; Zhihong Wu; Nan Wu
Journal:  Hum Genet       Date:  2016-11-02       Impact factor: 4.132

5.  Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9.

Authors:  Chul-Yong Park; Jin Jea Sung; Sung-Rae Cho; Jongwan Kim; Dong-Wook Kim
Journal:  Stem Cell Reports       Date:  2019-05-16       Impact factor: 7.765

6.  MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling.

Authors:  Zheng-Jun Zhou; Chu-Bin Luo; Hao-Yang Xin; Zhi-Qiang Hu; Gui-Qi Zhu; Jia Li; Shao-Lai Zhou
Journal:  NPJ Genom Med       Date:  2020-04-01       Impact factor: 8.617

Review 7.  Towards accurate and reliable resolution of structural variants for clinical diagnosis.

Authors:  Zhichao Liu; Ruth Roberts; Timothy R Mercer; Joshua Xu; Fritz J Sedlazeck; Weida Tong
Journal:  Genome Biol       Date:  2022-03-03       Impact factor: 17.906

8.  Reconstruction of Secondary Metabolic Pathway to Synthesize Novel Metabolite in Saccharopolyspora erythraea.

Authors:  Chong-Yang Ren; Yong Liu; Wen-Ping Wei; Junbiao Dai; Bang-Ce Ye
Journal:  Front Bioeng Biotechnol       Date:  2021-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.